NTC news: Post-cataract surgery23 Jul 2019
Last June, in Milan, NTC held a very important Investigators’ Meeting of two pivotal registration studies for a novel drug indicated in post cataract surgery: over 50 centers were involved in such large clinical effort and attended the event.
NTC is fostering antibiotic culture in an environment largely impacted by antibiotic resistance, promoting innovation and creating new therapeutic solutions available on worldwide scale.
NTC‘s products are supported by significant evidence based medicine leveraging large randomized clinical trials.
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation